The Biomed 2 Demonstration Programme on Inherited Breast Cancer

Learn More
There appears to be no report on the use of invasive procedures (fine needle aspiration or core biopsies) in high-risk clinics dedicated to early diagnosis and treatment of inherited breast cancer. Such information is required for various reasons: It is requested by the patient at genetic counselling, it is a putative capacity problem at the departments(More)
As described in the accompanying abstract " Effectiveness of early diagnosis of inherited breast cancer " , 5-year event-free survival of prospectively detected inherited breast cancer is > 80%. This is substantially better than retrospective reports on BRCA1 mutation carriers. The diagnosed cancers were in young women. In both the Norwegian and Manchester(More)
  • 1